Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Estradiol Transdermal System Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Estradiol Transdermal System Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 0.025 mg per day
      • 1.3.3 0.0375 mg per day
      • 1.3.4 0.05 mg per day
      • 1.3.5 0.075 mg per day
      • 1.3.6 0.1 mg per day
    • 1.4 Market Segment by Application
      • 1.4.1 Global Estradiol Transdermal System Market Share by Application (2019-2025)
      • 1.4.2 Hot flashes
      • 1.4.3 Prevention of postmenopausal osteoporosis
      • 1.4.4 Treatment of hypoestrogenism
      • 1.4.5 Moderate-to-severe vasomotor symptoms
      • 1.4.6 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Estradiol Transdermal System Market Size
      • 2.1.1 Global Estradiol Transdermal System Revenue 2014-2025
      • 2.1.2 Global Estradiol Transdermal System Sales 2014-2025
    • 2.2 Estradiol Transdermal System Growth Rate by Regions
      • 2.2.1 Global Estradiol Transdermal System Sales by Regions 2014-2019
      • 2.2.2 Global Estradiol Transdermal System Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Estradiol Transdermal System Sales by Manufacturers
      • 3.1.1 Estradiol Transdermal System Sales by Manufacturers 2014-2019
      • 3.1.2 Estradiol Transdermal System Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Estradiol Transdermal System Revenue by Manufacturers (2014-2019)
      • 3.2.2 Estradiol Transdermal System Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Estradiol Transdermal System Market Concentration Ratio (CR5 and HHI)
    • 3.3 Estradiol Transdermal System Price by Manufacturers
    • 3.4 Key Manufacturers Estradiol Transdermal System Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Estradiol Transdermal System Market
    • 3.6 Key Manufacturers Estradiol Transdermal System Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 0.025 mg per day Sales and Revenue (2014-2019)
      • 4.1.2 0.0375 mg per day Sales and Revenue (2014-2019)
      • 4.1.3 0.05 mg per day Sales and Revenue (2014-2019)
      • 4.1.4 0.075 mg per day Sales and Revenue (2014-2019)
      • 4.1.5 0.1 mg per day Sales and Revenue (2014-2019)
    • 4.2 Global Estradiol Transdermal System Sales Market Share by Type
    • 4.3 Global Estradiol Transdermal System Revenue Market Share by Type
    • 4.4 Estradiol Transdermal System Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Estradiol Transdermal System Sales by Application

    6 United States

    • 6.1 United States Estradiol Transdermal System Breakdown Data by Company
    • 6.2 United States Estradiol Transdermal System Breakdown Data by Type
    • 6.3 United States Estradiol Transdermal System Breakdown Data by Application

    7 European Union

    • 7.1 European Union Estradiol Transdermal System Breakdown Data by Company
    • 7.2 European Union Estradiol Transdermal System Breakdown Data by Type
    • 7.3 European Union Estradiol Transdermal System Breakdown Data by Application

    8 China

    • 8.1 China Estradiol Transdermal System Breakdown Data by Company
    • 8.2 China Estradiol Transdermal System Breakdown Data by Type
    • 8.3 China Estradiol Transdermal System Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Estradiol Transdermal System Breakdown Data by Company
    • 9.2 Rest of World Estradiol Transdermal System Breakdown Data by Type
    • 9.3 Rest of World Estradiol Transdermal System Breakdown Data by Application
    • 9.4 Rest of World Estradiol Transdermal System Breakdown Data by Countries
      • 9.4.1 Rest of World Estradiol Transdermal System Sales by Countries
      • 9.4.2 Rest of World Estradiol Transdermal System Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 Novartis
      • 10.1.1 Novartis Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.1.4 Estradiol Transdermal System Product Introduction
      • 10.1.5 Novartis Recent Development
    • 10.2 Allergan
      • 10.2.1 Allergan Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.2.4 Estradiol Transdermal System Product Introduction
      • 10.2.5 Allergan Recent Development
    • 10.3 Bayer
      • 10.3.1 Bayer Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.3.4 Estradiol Transdermal System Product Introduction
      • 10.3.5 Bayer Recent Development
    • 10.4 Noven Therapeutics
      • 10.4.1 Noven Therapeutics Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.4.4 Estradiol Transdermal System Product Introduction
      • 10.4.5 Noven Therapeutics Recent Development
    • 10.5 Mylan
      • 10.5.1 Mylan Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.5.4 Estradiol Transdermal System Product Introduction
      • 10.5.5 Mylan Recent Development
    • 10.6 Vertical Pharmaceuticals
      • 10.6.1 Vertical Pharmaceuticals Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.6.4 Estradiol Transdermal System Product Introduction
      • 10.6.5 Vertical Pharmaceuticals Recent Development
    • 10.7 Perrigo Pharma International
      • 10.7.1 Perrigo Pharma International Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Estradiol Transdermal System
      • 10.7.4 Estradiol Transdermal System Product Introduction
      • 10.7.5 Perrigo Pharma International Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Estradiol Transdermal System Sales Channels
      • 11.2.2 Estradiol Transdermal System Distributors
    • 11.3 Estradiol Transdermal System Customers

    12 Market Forecast

    • 12.1 Global Estradiol Transdermal System Sales and Revenue Forecast 2019-2025
    • 12.2 Global Estradiol Transdermal System Sales Forecast by Type
    • 12.3 Global Estradiol Transdermal System Sales Forecast by Application
    • 12.4 Estradiol Transdermal System Forecast by Regions
      • 12.4.1 Global Estradiol Transdermal System Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Estradiol Transdermal System Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Estradiol is in a class of medications called estrogen hormones. It works by replacing estrogen that is normally produced by the body. Most brands of estradiol transdermal patches are used to treat hot flushes (hot flashes; sudden strong feelings of heat and sweating) and/or vaginal dryness, itching, and burning in women who are experiencing menopause (change of life; the end of monthly menstrual periods). Transdermal estradiol is also used to prevent osteoporosis (a condition in which the bones become thin and weak and break easily) in women who are experiencing or have experienced menopause.
      In 2019, the market size of Estradiol Transdermal System is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Estradiol Transdermal System.

      This report studies the global market size of Estradiol Transdermal System, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Estradiol Transdermal System sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Novartis
      Allergan
      Bayer
      Noven Therapeutics
      Mylan
      Vertical Pharmaceuticals
      Perrigo Pharma International
      ...

      Market Segment by Product Type
      0.025 mg per day
      0.0375 mg per day
      0.05 mg per day
      0.075 mg per day
      0.1 mg per day

      Market Segment by Application
      Hot flashes
      Prevention of postmenopausal osteoporosis
      Treatment of hypoestrogenism
      Moderate-to-severe vasomotor symptoms
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Estradiol Transdermal System status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Estradiol Transdermal System manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Estradiol Transdermal System are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now